Journal Information
Vol. 42. Issue 5.
Pages 207-210 (May 2006)
Share
Share
Download PDF
More article options
Vol. 42. Issue 5.
Pages 207-210 (May 2006)
Editorial
Full text access
Health Economics: the Cost of Illness and Economic Evaluation in Respiratory Diseases
Visits
5118
J. López-Bastida
Corresponding author
jlopbas@gobiernodecanarias.org

Correspondence: Dr J. López-Bastida. Pérez de Rozas, 5, 4.°. 38004 Santa Cruz de Tenerife. España
Servicio de Evaluación y Planificación, Hospital Universitario Nuestra Señora de la Candelaria, Servicio Canario de la Salud, Santa Cruz de Tenerife, Spain
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
RW Evans.
Health care technology and the inevitability of resource allocation and rationing decisions—part I.
JAMA., 249 (1983), pp. 2047-2053
[2]
JP Newhouse.
Medical care costs: how much welfare loss?.
Journal of Economic Perspectives, 6 (1992), pp. 3-21
[3]
RN Battista.
Innovation and diffusion of health related technologies: a conceptual framework.
Int J Technol Assess Health Care, 5 (1989), pp. 227-248
[4]
L Borderías Clau, M Zabaleta Murguionda, JA Riesco Miranda, C Pellicer Ciscar, JR Hernández Hernández, T Carrillo Díaz, et al.
Coste y manejo de una crisis asmática en el ámbito hospitalario de nuestro medio (estudio COAX en servicios hospitalarios).
Arch Bronconeumol., 41 (2005), pp. 313-321
[5]
J de Miguel Díez.
Farmaeconomía en el asma y en la EPOC.
Arch Bronconeumol., 41 (2005), pp. 239-241
[6]
JF Masa, V Sobradillo, C Villasante, CA Jiménez-Ruiz, L Fernandez-Fau, JL Viejo, et al.
Costes de la EPOC en España. Estimación a partir de un estudio epidemiológico poblacional.
Arch Bronconeumol., 40 (2004), pp. 72-79
[7]
MF Drummond, B O'Brien, GL Stoddart, GW Torrance.
Methods for the economic evaluation of health care programmes, 2nd ed., Oxford University Press, (1997),
[8]
MR Gold, JE Siegel, LB Russell, MC Weinstein.
Cost-effectiveness in health and medicine, Oxford University Press, (1996),
[9]
AJ García Ruiz, F Leiva Fernández, F Martos Crespo.
Análisis del coste-eficacia del tiotropio frente al ipatropio y salmeterol.
Arch Bronconeumol., 41 (2005), pp. 242-248
[10]
DP Rice.
Cost-of-illness studies: fact or fiction?.
Lancet, 344 (1994), pp. 1519-1520
[11]
R Brooks.
EuroQol: the current state of play.
Health Policy, 37 (1996), pp. 53-72
[12]
MF Drummond, TO Jefferson.
Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.
BMJ., 313 (1996), pp. 275-283
[13]
GW Torrance.
Measurement of health state utilities for economic appraisal. A review.
Journal of Health Economics, 5 (1986), pp. 1-30
[14]
M Drummond.
Australian guidelines for cost-effectiveness studies of pharmaceuticals: the thin end of the boomerang? Centre for Health Economics, University of York, (1991),
Copyright © 2006. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?